UOC
AZN icon

UBS O'Connor’s AstraZeneca AZN Stock Holding History

UBS O'Connor’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,499
Closed -$3M – 299
2025
Q2 		$3M Buy
21,499
+18,193
+550% +$2.55M 0.08% 115
2025
Q1 		$486K Sell
3,306
-27,418
-89% -$3.97M 0.01% 223
2024
Q4 		$4.03M Buy
+30,724
New +$4.3M 0.1% 99
2024
Q2 		– Sell
-27,142
Closed -$4.08M – 547
2024
Q1 		$3.68M Buy
27,142
+11,108
+69% +$1.47M 0.11% 109
2023
Q4 		$2.16M Sell
16,034
-8,737
-35% -$1.14M 0.07% 161
2023
Q3 		$3.35M Buy
24,771
+8,000
+48% +$1.09M 0.06% 169
2023
Q2 		$2.4M Sell
16,771
-5,829
-26% -$858K 0.05% 247
2023
Q1 		$3.14M Buy
22,600
+7,076
+46% +$952K 0.07% 200
2022
Q4 		$2.1M Sell
15,524
-32,691
-68% -$4.1M 0.04% 457
2022
Q3 		$5.29M Buy
48,215
+7,500
+18% +$951K 0.06% 202
2022
Q2 		$5.38M Buy
40,715
+16,794
+70% +$2.2M 0.06% 214
2022
Q1 		$3.17M Buy
+23,921
New +$2.87M 0.03% 414
2019
Q2 		– Sell
-50,000
Closed -$4.04M – 257
2019
Q1 		$4.04M Buy
+50,000
New +$3.94M 0.11% 117
2015
Q1 		– Sell
-88,398
Closed -$6.22M – 763
2014
Q4 		$6.22M Hold
88,398
– – 0.11% 182
2014
Q3 		$6.32M Hold
88,398
– – 0.11% 194
2014
Q2 		$6.57M Buy
+88,398
New +$6.39M 0.04% 177

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS O'Connor's AZN Position: Q3 2025 in Review

UBS O'Connor sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 21,499 shares — an estimated $3M sold.

UBS O'Connor first reported a position in AZN in Q2 2014 and held it in 16 quarters. The position peaked at $6.57M in Q2 2014. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • UBS O'Connor reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 21,499 AstraZeneca shares in Q3 2025, an estimated $3M.
  • UBS O'Connor first reported a position in AstraZeneca in Q2 2014 and held it in 16 quarters.
  • UBS O'Connor's AstraZeneca position peaked at $6.57M in Q2 2014.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.